About Us

We are a clinical-stage biopharmaceutical company leveraging our proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Our platform enables us to strategically pair linker-payloads that modulate key disease-modifying pathways with monoclonal antibodies directed to specific disease sites.

Initially, we are creating a new class of targeted immuno-oncology agents that direct a myeloid cell activator to the tumor microenvironment in solid tumors to promote cancer cell killing.

Our Purpose

Inspired by patients. Driven by data. Powered by science. These are just a few values that help describe who Silverback is, but our commitment and purpose go deeper.

Our Purpose

Inspired by patients. Driven by data. Powered by science. These are just a few values that help describe who Silverback is, but our commitment and purpose go deeper.

The Silverback Team

Our team includes some of the industry’s most accomplished leaders, scientists, drug developers and clinicians. What makes us who we truly are is our shared passion for bringing victories to patients.

Management Team

Laura Shawver, Ph.D.

Chief Executive Officer

Valerie Odegard, Ph.D.

President & Chief Scientific Officer

Naomi Hunder, M.D.

Chief Medical Officer

Jonathan Piazza

Chief Financial Officer

Jeffrey Pepe, Ph.D., J.D.

Senior Vice President and General Counsel

Sateesh Natarajan, Ph.D.

Senior Vice President of CMC Development

Scott Moorefield, Ph.D.

Senior Vice President of Business Development

Russ Hawkinson

Senior Vice President of Finance

Laura Shawver, Ph.D.

Chief Executive Officer

Valerie Odegard, Ph.D.

President & Chief Scientific Officer

Naomi Hunder, M.D.

Chief Medical Officer

Jonathan Piazza

Chief Financial Officer

Jeffrey Pepe, Ph.D., J.D.

Senior Vice President and General Counsel

Sateesh Natarajan, Ph.D.

Senior Vice President of CMC Development

Scott Moorefield, Ph.D.

Senior Vice President of Business Development

Russ Hawkinson

Senior Vice President of Finance

Jeffrey Adamo

Scientist, Protein Engineering

Andrew Alwood, C.P.A.

Director, Finance

Miguel Arcinas

Senior Director, Corporate Development & Investor Relations

Jeannette Bannink

Director, Bioanalytical

Peter Baum, Ph.D.

Vice President, Immunology

Steph Best

Administrative Assistant

Cecile Blois

Associate Scientist, Protein Engineering

Lisa Bogatzki

Scientist, Bioanalytical

Jamie Brevik

Associate Scientist, In vivo Biology

Robert Burris, M.B.A., C.P.A.

Accounting Manager

Katie Carrigan

Vice President, Human Resources

Ray Carrillo

Senior Research Associate, Protein Engineering

Jenny Chang, Ph.D.

Senior Scientist I, Bioconjugation Chemistry

Monica Childs

Scientist, Discovery Biology

Michael Comeau

Principal Scientist, Discovery Biology

Jonathan Crane, Ph.D.

Principal Scientist, BioAssay Development

Mollie Daugherty

Senior Scientist I, Developability & Preformulation

Bob DuBose, Ph.D.

Executive Director, Research Informatics

Li-Qun Fan

Senior Scientist II, Protein Engineering

Jake Felcyn

Senior Research Associate II, Bioanalysis

Jon Grey

Scientist, Synthetic Chemistry

Sue Hamke

Vice President, Clinical Operations

Elsa Hay

Associate Scientist, Discovery Biology

Jill Herendeen, Pharm.D.

Vice President, Regulatory

Jennifer Huttenburg

Director, Clinical Operations

Graham Jang, Ph.D., M.B.A.

Vice President, Development Sciences

Megan Kelly

Lab Operations Assistant

Yvette Latchman, Ph.D.

Senior Director, Biology

Patricia Leith, Pharm.D.

Vice President of Program Management and Operations

Doug MacDonald

Director, Antibody Process Development & Manufacturing

Heather Metz, Ph.D.

Senior Scientist I, In vivo Biology

Leslie Milligan-Yu

Senior Director, Data Management

Veronique Moleres

Executive Assistant

Eva Nachmanson, C.P.A.

Controller

Rachel Needham

Senior Scientist I, Discovery Biology

Linda Povinelli

Senior Contract Paralegal

Dave Purdy

Senior Scientist I, Chemistry

Marcus Rhodehamel

Research Associate, In vivo Biology

Ben Setter

Scientist, Protein Engineering

Sean Smith, Ph.D.

Senior Director, Chemistry

Brenda Stevens

Senior Scientist II, Protein Engineering

Phil Tan, Ph.D.

Executive Director, Protein Engineering

Antonia Tanczos

Senior Manager, Operations Services

Megan Williams, Ph.D., M.B.A.

Senior Director, Program Management

Damion Winship

Senior Research Associate II, In vivo Biology

Carina Xu, Ph.D.

Principal Scientist, Protein Engineering

Board of Directors

Peter Thompson, M.D.

Chair of the Board & Co-founder
of Silverback Therapeutics

Vickie L. Capps

Board Member

Jon Root, M.D.

Board Member

Recent News

Press Releases

© Copyright 2021 - Silverback Therapeutics®️ | All Rights Reserved | Terms of Use